The reality here on current timelines by June/July next year more than likely there will be a binary trial outcome for this drug. Like Whytee, while be being positive, I’ve invested in biotech for long enough (and been burnt) to know there’s no such think as a sure thing when it comes to trial results. Having said that I am sure in the lead up to trial readout provided ongoing funding is sorted in a not too dilutive manner the share price will appreciate significantly so there will be money to be made here irrespective if one holds to that readout.
The reality here on current timelines by June/July next year...
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
48.5¢ |
Change
-0.035(6.73%) |
Mkt cap ! $321.4M | |||
| Open | High | Low | Value | Volume |
| 50.5¢ | 50.5¢ | 47.5¢ | $314.0K | 642.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3270 | 48.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 49.5¢ | 9056 | 2 |
View Market Depth
| Last trade - 16.10pm 06/06/2024 (20 minute delay) ? |
|
|||||
|
Last
48.5¢ |
Change
-0.035 ( 6.73 %) |
||||
| Open | High | Low | Volume | ||
| 49.0¢ | 50.0¢ | 47.5¢ | 78801 | ||
| Last updated 15.59pm 06/06/2024 ? | |||||
| OPT (ASX) Chart |